Wellington Management Group LLP Purchases 857,526 Shares of Revvity Inc. $RVTY

Wellington Management Group LLP increased its position in Revvity Inc. (NYSE:RVTY) by 10,653.8% in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 865,575 shares of the company’s stock after acquiring an additional 857,526 shares during the quarter. Wellington Management Group LLP owned about 0.78% of Revvity worth $96,304,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Ascentis Independent Advisors purchased a new stake in shares of Revvity during the 1st quarter valued at approximately $29,000. CYBER HORNET ETFs LLC purchased a new stake in shares of Revvity during the second quarter worth $32,000. MUFG Securities EMEA plc purchased a new stake in shares of Revvity during the second quarter worth $34,000. SJS Investment Consulting Inc. boosted its holdings in shares of Revvity by 5,210.0% in the first quarter. SJS Investment Consulting Inc. now owns 531 shares of the company’s stock worth $47,000 after acquiring an additional 521 shares during the period. Finally, Headlands Technologies LLC bought a new position in shares of Revvity in the second quarter worth $49,000. 86.65% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

RVTY has been the topic of a number of analyst reports. Stifel Nicolaus decreased their price objective on Revvity from $110.00 to $100.00 and set a “hold” rating on the stock in a research note on Wednesday, May 6th. Wall Street Zen lowered Revvity from a “buy” rating to a “hold” rating in a report on Sunday, August 16th. Robert W. Baird set a $117.00 price target on Revvity in a research report on Wednesday, May 6th. Evercore restated an “outperform” rating on shares of Revvity in a research report on Wednesday, August 5th. Finally, Barclays boosted their price objective on shares of Revvity from $95.00 to $105.00 and gave the company an “equal weight” rating in a research note on Thursday, May 7th. Three investment analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $110.58.

Revvity Price Performance

Shares of NYSE RVTY opened at $126.59 on Wednesday. The firm has a market capitalization of $14.13 billion, a P/E ratio of 60.28, a P/E/G ratio of 2.34 and a beta of 1.09. The company has a quick ratio of 1.50, a current ratio of 1.80 and a debt-to-equity ratio of 0.36. The stock’s 50-day simple moving average is $115.22 and its two-hundred day simple moving average is $101.55. Revvity Inc. has a twelve month low of $81.22 and a twelve month high of $130.07.

Revvity (NYSE:RVTY) last released its quarterly earnings results on Tuesday, August 4th. The company reported $1.41 earnings per share for the quarter, beating the consensus estimate of $1.21 by $0.20. Revvity had a return on equity of 8.34% and a net margin of 8.16%.The firm had revenue of $729.69 million for the quarter, compared to analysts’ expectations of $702.96 million. During the same quarter last year, the firm posted $1.18 EPS. The company’s revenue was down 1.3% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. As a group, equities analysts anticipate that Revvity Inc. will post 5.36 EPS for the current fiscal year.

Revvity Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Friday, October 23rd will be given a dividend of $0.07 per share. The ex-dividend date is Friday, October 23rd. This represents a $0.28 annualized dividend and a yield of 0.2%. Revvity’s payout ratio is presently 13.33%.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.